Atossa Therapeutics Inc. Q2 Loss Increases, Misses Estimates
(RTTNews) - Atossa Therapeutics Inc. (ATOS) revealed Loss for its second quarter that increased from last year and missed the Street estimates.
The company's earnings totaled -$8.42 million, or -$0.07 per share. This compares with -$6.05 million, or -$0.05 per share, last year.
Analysts on average had expected the company to earn -$0.06 per share. Analysts' estimates typically exclude special items.
Atossa Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$8.42 Mln. vs. -$6.05 Mln. last year. -EPS: -$0.07 vs. -$0.05 last year.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.